More from Curaleaf

Curaleaf Laboratories Wins Cannabis Team of the Year at the Business of Cannabis Awards 2026

Recognised for Innovation, Quality, Education and Leadership in Medical Cannabis Curaleaf Laboratories is proud to announce that we have been awarded Cannabis Team of the Year at the Business of Cannabis Awards, recognising our commitment to innovation, pharmaceutical excellence and leadership within the UK medical cannabis industry. This award reflects the dedication, expertise and passion […]

420 and the UK Medical Cannabis Sector: Beyond the Noise

Every year, 20th April brings a familiar wave of headlines, commentary and public discussion about cannabis. For many people, 420 remains a cultural reference point, shaped by symbolism, visibility, and a long-standing association with cannabis. That is the part most people see. The more important story in the UK is what sits behind the public […]

Curaleaf Laboratories Enters Strategic Partnership with ANTG to Manufacture and Distribute Medicinal Cannabis Products in the UK

London, UK – 12th November, 2025 – Curaleaf Laboratories, one of the UK’s leading providers of medicinal cannabis products, is pleased to announce a landmark partnership with Australian Natural Therapeutics Group (ANTG), one of Australia’s most respected producers of pharmaceutical-grade medicinal cannabis. Under this agreement, Curaleaf Laboratories will manufacture and distribute ANTG’s range of products […]